Oxygenta Pharmaceutical (BOM:524636) Change In Receivables : ₹0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Change In Receivables?

Oxygenta Pharmaceutical's change in receivables for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means Oxygenta Pharmaceutical's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Oxygenta Pharmaceutical's change in receivables for the fiscal year that ended in Mar. 2024 was ₹32.0 Mil. It means Oxygenta Pharmaceutical's Accounts Receivable declined by ₹32.0 Mil from Mar. 2023 to Mar. 2024 .

Oxygenta Pharmaceutical's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹73.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Oxygenta Pharmaceutical's Days Sales Outstanding for the three months ended in Mar. 2024 was 63.65.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Oxygenta Pharmaceutical's liquidation value for the three months ended in Mar. 2024 was ₹-708.4 Mil.

Oxygenta Pharmaceutical Change In Receivables Historical Data

The historical data trend for Oxygenta Pharmaceutical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Change In Receivables Chart

Oxygenta Pharmaceutical Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

6.98

-9.45

-1.49

-86.12

31.96

Oxygenta Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Oxygenta Pharmaceutical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Oxygenta Pharmaceutical (BOM:524636) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Oxygenta Pharmaceutical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	73.606	/	105.524	*	91
=	63.65

2. In Ben Graham's calculation of liquidation value, Oxygenta Pharmaceutical's accounts receivable are only considered to be worth 75% of book value:

Oxygenta Pharmaceutical's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.008	-	833.145	+	0.75 * 73.606	+	0.5 * 137.165
=	-708.4

Oxygenta Pharmaceutical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines